Distinct effects of anti-tumor necrosis factor combined therapy on TH1/TH2 balance in rheumatoid arthritis patients

Keyphrases

• Anti-tumor Necrosis Factor (anti-TNF) 100%
• Anti-tumor Necrosis Factor Therapy 25%
• Apoptosis Induction 50%
• Apoptotic Cells 25%
• CCR4 25%
• CD4 Cells 50%
• Chemokine Receptor 50%
• Combined Therapy 100%
• CXCR3 25%
• Cytokine Receptor 25%
• Flow Cytometric Analysis 25%
• Flow Image 25%
• IL-12 Receptor 25%
• IL-4Rα 25%
• Image Analysis 25%
• Immune Balance 25%
• Immune Markers 25%
• Inflammation 25%
• Lymphocyte Subsets 25%
• Lymphocytes 25%
• Meta-analysis 25%
• Methotrexate 50%
• Methotrexate Chemotherapy 25%
• Methotrexate Treatment 25%
• Rheumatoid Arthritis 25%
• Rheumatoid Arthritis Patients 100%
• Therapeutic Effect 25%
• TNF Blockers 50%

Immunology and Microbiology

• CD4 40%
• Chemokine Receptor 20%
• Chemokine Receptor CCR4 20%
• CXCR3 20%
• Cytokine Receptor 20%
• down Regulation 20%
• Inflammatory Arthritis 100%
• Lymphocyte 20%
• Lymphocyte Subpopulation 20%
• Methotrexate 80%
• Percentage of Apoptotic Cells 20%
• Tumor Necrosis Factor 100%